Evidence map›Paper›PMID 11313869›Full record

ArticleOncogene2001

Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities.

B Bilanges, A Varrault, A Mazumdar, C Pantaloni, A Hoffmann, J Bockaert, D Spengler, L Journot

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Biology open · 2018
    Article
  4. Oncotarget · 2018
    Article
  5. Chromosome 6q24-related diabetes mellitus.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2018
    Article
  6. Article
  7. Imprinted Zac1 in neural stem cells.World journal of stem cells · 2015
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Regulation of cardiomyocyte Glut4 expression by ZAC1.The Journal of biological chemistry · 2010
    Article
  17. Article
  18. Article
  19. Article
  20. Neonatal diabetes mellitus.Endocrine reviews · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

B BilangesMécanismes Moléculaires des Communications Cellulaires, UPR 9023 CNRS, 141 rue de la Cardonille, F-34094 Montpellier Cedex 05, France.
A Varrault
A Mazumdar
C Pantaloni
A Hoffmann
J Bockaert
D Spengler
L Journot
Centre National de la Recherche Scientifique · FRMax Planck Institute of Psychiatry · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ZAC encodes a zinc finger protein with antiproliferative activity, is maternally imprinted and is a candidate for the tumor suppressor gene on 6q24. ZAC expression is frequently lost in breast and ovary tumor-derived cell lines and down-regulated in breast primary tumors. In this report, we describe ZACDelta2, an alternatively spliced variant of ZAC lacking the sequence encoding the two N-terminal zinc fingers. Messenger RNAs encoding ZAC or ZACDelta2 were equally abundant and both proteins were nuclear. ZACDelta2 displayed an improved transactivation activity and an enhanced affinity for a ZAC binding site, suggesting that the two N-terminal zinc fingers negatively regulated ZAC binding to its target DNA sequences. Both proteins were equally efficient in preventing colony formation, indicating similar overall antiproliferative activities. However, these activities resulted from a differential regulation of apoptosis vs cell cycle progression since ZACDelta2 was more efficient at induction of cell cycle arrest than ZAC, whereas it was the reverse for apoptosis induction. Hence, these data further underline that ZAC gene is critically controlled, both at the transcriptional level through imprinting and at the functional level through alternative splicing.

Indexed as

Alternative SplicingApoptosisBase SequenceBlotting, WesternBreast NeoplasmsCell Cycle ProteinsChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsDNA PrimersElectrophoresis, Agar GelEpithelial CellsFemaleFlow CytometryGC Rich SequenceGene DeletionGenes, Tumor SuppressorCell Cycle ProteinsChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsDNA PrimersPLAGL1 protein, humanRNA, MessengerTrans-ActivatorsTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID11313869
OpenAlexW2315990821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.